Antidepressant augmentation and co-initiation treatment in acute major depressive disorder: A systematic review, meta-analysis and metaregression analysis

被引：0
|
作者：
Galling, B. [1 ,2 ,3 ]
Correll, C. U. [1 ,2 ,3 ]
机构：
[1] Charite Univ Med Berlin, Child & Adolescent Psychiat, Berlin, Germany
[2] Hofstra Northwell Sch Med, Dept Psychiat & Mol Med, Hempstead, NY USA
[3] Zucker Hillside Hosp, Psychiat Res, Glen Oaks, NY USA
来源：
EUROPEAN PSYCHIATRY | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
PW0277
引用
收藏
页码：S203 / S203
页数：1
相关论文
共 50 条
  • [1] Antidepressant augmentation and co-initiation treatment in acute major depressive disorder: a systematic review, meta-analysis and metaregression analysis
    Galling, B.
    Sangroula, D.
    Ferrer, A. Calsina
    Correll, C. U.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S459 - S459
  • [2] Antipsychotic co-initiation versus monotherapy in schizophrenia: a systematic review, meta-analysis and metaregression analysis
    Roldan, A.
    Galling, B.
    Correll, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S537 - S538
  • [3] Antidepressant augmentation of antipsychotics in schizophrenia: a systematic review, meta-analysis and metaregression analysis
    Galling, B.
    Correll, C. U.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S946 - S947
  • [4] Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis
    Galling, Britta
    Calsina Ferrer, Amat
    Daou, Margarita Abi Zeid
    Sangroula, Dinesh
    Hagi, Katsuhiko
    Correll, Christoph U.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (10) : 1587 - 1608
  • [5] Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis
    Guinart, D.
    Galling, B.
    Sangroula, D.
    Ferrer, A. Calsina
    Correll, C. C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S414 - S415
  • [6] Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis
    Ahmad, Abdullah
    Awan, Abdul Rafeh
    Nadeem, Natasha
    Javed, Aamir Shahid
    Farooqi, Mobeen
    Daniyal, Muhammed
    Mumtaz, Hassan
    [J]. FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [7] Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta-analysis
    Kishi, Taro
    Sakuma, Kenji
    Hatano, Masakazu
    Matsuda, Yuki
    Esumi, Satoru
    Miyake, Nobumi
    Miura, Itaru
    Hori, Hikaru
    Kato, Masaki
    Iwata, Nakao
    [J]. NEUROPSYCHOPHARMACOLOGY REPORTS, 2024, 44 (01) : 216 - 220
  • [8] Theta burst stimulation for the acute treatment of major depressive disorder: A systematic review and meta-analysis
    Jeffrey D. Voigt
    Andrew F. Leuchter
    Linda L. Carpenter
    [J]. Translational Psychiatry, 11
  • [9] The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: A systematic review and meta-analysis
    Meeker A.S.
    Herink M.C.
    Haxby D.G.
    Hartung D.M.
    [J]. Systematic Reviews, 4 (1)
  • [10] Escitalopram vs duloxetine in acute treatment of major depressive disorder : meta-analysis and systematic review
    Maneeton, Benchalak
    Maneeton, Narong
    Likhitsathian, Surinporn
    Woottiluk, Pakapan
    Wiriyacosol, Punjaree
    Boonyanaruthee, Vudhichai
    Srisurapanont, Manit
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 1953 - 1961
12345